Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIT-HF Study
NCT05572957Active, not recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2022
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in Non-Ischaemic Cardiomyopathy (NICM), heart failure (HF) and Left bundle branch block (LBBB) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Proportion of patients requiring ICD implantation for prevention of sudden cardiac death (SCD) at 6 months. Started Oct 2022; status: active, not recruiting.
02
Conditions
Non-Ischaemic Cardiomyopathy (NICM)heart failure (HF)Left bundle branch block (LBBB)
Beyond the preview
Go deeper on NCT05572957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05572957.